India already produces 20% of the world’s generic drugs and 60% of global vaccines, cementing its position as a critical node in global pharma supply chains.
Recent Posts
- Top Gainers & Losers on Mar 30: Hindustan Copper, Tata Motors, Ceat, OLA, Canara Bank, Paytm among top losers
- Rupee’s worst performance since 2013 taper tantrum: How worrying is the decline?
- Indian rupee slips past 95 mark for first time amid escalating US-Iran war. Can it touch 100 per dollar?
- Commodity Radar: Despite gold’s Rs 55,000 fall from peak, only limited upside and not a breakaway rally seen: Here’s why
- Global Markets | European stocks steady ahead of inflation data